Frontal balding is associated with a virilizing ovarian or adrenal tumor. Central obesity with a hip ratio of > 0.85 is associated with cardiovascular disease and is a marker for PCOS. A "buffalo ...

GSK said on Friday the addition of its cancer drug Jemperli to both standard of care chemotherapy and Zejula maintenance ...

Perhaps PD-1 inhibitors just aren’t for ovarian cancer after all. | Merck's and GSK's similar overall survival setbacks ...

Every woman has a one in 87 chance of getting ovarian cancer in her lifetime, and one in 130 will die from it. The symptoms ...

From reprogrammed stem cells to next-generation gene editing, 2024 has seen some incredible developments with the potential to become new treatments.

Acanthosis nigricans, a dark and hyperpigmented hyperplasia of the skin typically found at the nape of the neck and axilla, is a marker for insulin resistance. Acanthosis nigricans is usually ...

GSK has announced positive results from a phase III trial of its ovarian cancer treatment, which met its primary endpoint of ...

WellTheory, a platform focused on reducing autoimmune disease symptoms, is launching a new women’s health program focused on ...

But new blood tests are emerging that use the power of artificial intelligence (AI) to spot signs of the cancer in its very ...

A number of ovarian cancer vaccines are being evaluated including the world's first cancer prevention vaccine, which recently ...

Women who have PCOS find it difficult to lose weight due to hormonal imbalances caused by the condition. While this can make ...

An MRI-based imaging technique developed at the University of Cambridge could be used to predict the response of ovarian ...